RF
VAXX

Robinswood Financial’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Robinswood Financial’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-55
Closed -$13 – 394
2024
Q2 		$13 Hold
55
– – ﹤0.01% 363
2024
Q1 		$39 Hold
55
– – ﹤0.01% 247
2023
Q4 		$46 Hold
55
– – ﹤0.01% 244
2023
Q3 		$75 Hold
55
– – ﹤0.01% 243
2023
Q2 		$138 Buy
+55
New +$117 ﹤0.01% 218

Robinswood Financial's VAXX Position: Q3 2024 in Review

Robinswood Financial sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q3 2024, closing a stake of 55 shares — an estimated $13 sold.

Robinswood Financial first reported a position in VAXX in Q2 2023 and held it in 5 quarters. The position peaked at $138 in Q2 2023. 0 funds tracked by Wall St. Rank hold VAXX as of Q3 2024.

  • Robinswood Financial reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
  • Robinswood Financial sold 55 Vaxxinity, Inc. Class A Common Stock shares in Q3 2024, an estimated $13.
  • Robinswood Financial first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 5 quarters.
  • Robinswood Financial's Vaxxinity, Inc. Class A Common Stock position peaked at $138 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2024.

Based on Robinswood Financial's 13F filing for Q3 2024, filed 15 Jul 2026.